跳至主要内容
临床试验/NCT02663570
NCT02663570Unknown不适用

Effects of 6 Months of Melatonin Treatment on Clinical, Endocrine ed Metabolic Features in Women Affected by PCOS

Catholic University of the Sacred Heart1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Number of cycles in six months of therapy

研究概览

简要总结

The aim of our study is to investigate the effects of a treatment with melatonin on clinical, endocrine and metabolic features in women affected by PCOS. The study group included 40 patients treatend with 2 mg of melatonin daily for six months. Menstrual pattern, anthropometric parameters, hirsutism score, ultrasound ovarian volume and antral follicular count, an oral glucose tollerance test and hormonal assays are evaluated before and after therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • women with PCOS in accordance with Rotterdam criteria

排除标准

  • pregnancy
  • past history of cardiovascular diseases
  • diabetes mellitus (or impaired glucose tolerance as determined by a standard 75 gr oral glucose tolerance test)
  • hypertension
  • significant liver or renal impairment
  • other hormonal dysfunction (hypothalamic, pituitary, thiroidal or adrenal)
  • neoplasms

研究组 & 干预措施

open

Experimental

therapy with melatonin 2 mg daily for six months

干预措施: Melatonin (Drug)

结局指标

主要结局

Number of cycles in six months of therapy

时间窗: 6 months

次要结局

  • free androgen index(6 months)
  • insulin levels(6 months)
  • tryglycerides(6 months)
  • hirsutism score(6 months)
  • LDL cholesterol(6 months)
  • androstenedione levels(6 months)
  • AMH levels(6 months)
  • testosterone levels(6 months)
  • total cholesterol(6 months)
  • HDL cholesterol(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rosanna Apa

Professor

Catholic University of the Sacred Heart

研究点 (1)

Loading locations...

相似试验